e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
Singh Dave, Kolsum Umme, Brightling Chris E., Locantore Nicholas, Agusti Alvar, Tal-Singer Ruth
Source:
Eur Respir J 2014; 44: 1697-1700
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Singh Dave, Kolsum Umme, Brightling Chris E., Locantore Nicholas, Agusti Alvar, Tal-Singer Ruth. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J 2014; 44: 1697-1700
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006
Bronchiectasis prevalence and relationship with clinical features in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Eosinophilic inflammation and asthma control
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009
The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Clinical features of eosinophilic COPD
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Eosinophilic bronchitis as a cause of chronic cough: a systematic diagnostic evaluation
Source: Eur Respir J 2002; 20: Suppl. 38, 451s
Year: 2002
Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort
Source: Eur Respir J, 50 (4) 1700853; 10.1183/13993003.00853-2017
Year: 2017
Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Eosinophilic COPD
Source: Eur Respir Monogr 2022; 95: 100-118
Year: 2022
Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017
Severe asthma among adults: Prevalence and clinical characteristics
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018
Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Source: Eur Respir J 2003; 22: 8-13
Year: 2003
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation
Source: Eur Respir J 2006; 28: Suppl. 50, 449s
Year: 2006
Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept